艾昆纬-美印医学伙伴关系：印度对美国医疗体系的贡献（英）-2024.4-32页

VIP专享

3.0 村上 2024-09-03 90 16 3.77MB 32 页免费

侵权投诉

U.S.–India Medicine

Partnership

INDIA’S CONTRIBUTION TO THE U.S. HEALTHCARE SYSTEM

APRIL



Introduction

transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without

express written consent of IQVIA and the IQVIA Institute.

REFERENCING THIS REPORT

Please use this format when referencing content from this report:

Source: IQVIA Institute for Human Data Science. U.S.–India Medicine Partnership: India’s Contribution to the U.S. Healthcare System. April 2024.

Available from www.iqviainstitute.org

The supply of aordable medicines is crucial for the overall health of U.S.

residents and managing chronic health conditions. Indian pharmaceutical

companies play a critical role in supplying aordable medicines that enhance

patient access, improve management of health conditions, and bring

savings and sustainability to the overall health system. Concerns around the

geographic consolidation of manufacturing of key starting materials and active

pharmaceutical ingredients supply chain provide further opportunity for Indian

companies to partner with the U.S in de-risking the supply chain.

This report summarizes data on the importance of

generic medicines and their role in treating chronic

health conditions and providing savings to the U.S.

healthcare system. The contributions of Indian

companies to the U.S. drug supply are detailed in terms

of prescriptions, patient access, and savings.

We also characterize the state of the supply chain of

generic medicines, including the supply of key starting

materials and active pharmaceutical ingredients used

in manufacturing processes. The current state of the

supply chain presents challenges and opportunities

that could be potentially addressed through further

partnership with Indian pharmaceutical companies.

The study was produced independently by the

IQVIA Institute for Human Data Science, drawing on

proprietary IQVIA data. Funding for this report was

provided by the Indian Pharmaceutical Alliance.

The contributions to this report of Sebastian van der Ree

are gratefully acknowledged.

Find Out More

If you wish to receive future reports from the IQVIA

Institute for Human Data Science or join our mailing list,

visit iqviainstitute.org.

MURRAY AITKEN

Executive Director

IQVIA Institute for Human Data Science

U.S.–India Medicine Partnership: India’s Contribution to the U.S. Healthcare System

Table of Contents

Overview 2

 

 

 

 

 

Notes on sources 23

 

References 25

 

 

研报加载中……请稍候！
如果长时间未打开，您也可以点击刷新试试。

下载研报到电脑，查找使用更方便

免费 16人已下载

立即下载

标签： #美国 #印度

摘要：

U.S.–IndiaMedicinePartnershipINDIA’SCONTRIBUTIONTOTHEU.S.HEALTHCARESYSTEMAPRILIntroduction©2024IQVIAanditsaliates.Allreproductionrights,quotations,broadcasting,publicationsreserved.Nopartofthispublicationmaybereproducedortransmittedinanyformorbyanymeans,electronicormechanical,includingphotocopy...

展开>> 收起<<

艾昆纬-美印医学伙伴关系：印度对美国医疗体系的贡献（英）-2024.4-32页.pdf

共32页,预览10页

还剩页未读，继续阅读